PatrickDriscoll

I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Follow:
183 Articles

Medtech is Dead. Long Live Medtech.

The old Chinese saying, “May you live in interesting times”, is often…

PatrickDriscoll PatrickDriscoll

Bioengineered Skin & Skin Substitutes in Wound Care

Bioengineered skin was developed because of the need to cover extensive burn…

PatrickDriscoll PatrickDriscoll

Peripheral Arterial Disorders

Excerpt from, “Global Market Opportunities in Peripheral Arterial and Venous Stents, Forecast to…

PatrickDriscoll PatrickDriscoll

Peripheral Stents Heading to Far East

Stents, still a common clinical option in coronary ischemia, have migrated peripherally anatomically…

PatrickDriscoll PatrickDriscoll

Peripheral Vascular Stenting to 2020

First introduced about two decades ago as a bailout technique for suboptimal…

PatrickDriscoll PatrickDriscoll

Forecasts for neurointerventions in acute stroke

Over the past two decades, one could witness the advent and significant…

PatrickDriscoll PatrickDriscoll

Three Key Forces Behind Startups and Investment in Medical Technology

We see three key forces underlying investment trends in medical technology: We…

PatrickDriscoll PatrickDriscoll

Sutures, Staples and Other Fading Technologies

See Report #S192, “Worldwide Surgical Sealants, Glues, and Wound Closure Markets, 2013-2018”.…

PatrickDriscoll PatrickDriscoll

Technology advances in spine surgery

Manufacturers, clinicians and others focusing on technology advancement in spine surgery are…

PatrickDriscoll PatrickDriscoll

Vascular closure devices

[Vascular closure devices are among the products and technologies addressed in the…

PatrickDriscoll PatrickDriscoll